drugset / Trial / NCT00490893

Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir

NCT00490893

Phase 4 Terminated 12 enrolled University Hospital Tuebingen
RandomizedCrossoverSingle-blind

Summary

Hypoglycemia and unawareness of hypoglycemia are major problems of insulin therapy in patients with diabetes mellitus. The long acting insulin analogue Detemir has structural and physicochemical properties which differ from human insulin. The aim of the present study is to test whether this leads to altered hormone and symptom response during hypoglycemia.

Timeline

Start
2006-03
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin detemir Protein / enzyme biologic